Articles mentioning Bristol-Myers Squibb Co. (BMY)

Results 11 - 20 of 766 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY

Investing | February 16, 2015

Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?

Pfizer recently acquired Hospira for $17 billion, but it has plenty of fuel left to go after more deals to boost its pipeline and shareholder value.

Investing | February 15, 2015

Forget Traditional Chemotherapy! Could 3D Vaccines Eventually Cure Cancer?

Utilizing the body's immune system to help fight cancer is among the latest techniques researchers are using. However, this team of researchers has developed a truly unique new way of combating cancer.

Investing | February 14, 2015

Game-Changing News: Researchers May Have Discovered the Cause of Intestinal Cancer

Did researchers really uncover the mechanism behind intestinal cancer formation? Find out what game-changing news this latest study brings to light and how this could help drug developers plan their attack against intestinal cancers.

Investing | February 07, 2015

3 Drugs That Could Become Blockbusters in 2015

Pharmacyclics, Celgene Corp., Bristol-Myers Squibb, and Pfizer could see sales of new drugs eclipse $1 billion this year.

Investing | February 07, 2015

3 Blockbuster Drugs That May Be Obsolete in 5 Years

Motley Fool experts highlight three blockbuster-selling therapies that could fall by the wayside in the next five years.

Investing | February 04, 2015

5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know

Bristol-Myers Squibb this week held a conference call to discuss its fourth-quarter and full-year results. Here are five things management wants investors to know.

Investing | January 27, 2015

Bristol-Myers Squibb Co.'s Fourth Quarter Earnings Warn of a Tough Year Ahead

Bristol-Myers Squibb Co. reported its fourth quarter earnings Tuesday morning. Here's what investors need to know.

Investing | January 12, 2015

Bristol-Myers Squibb's New Cancer Drug Hits the Mark: What's Next?

Bristol-Myers Squibb announced that its closely-watched cancer drug, Opdivo, achieved a significant clinical milestone. Here's what you need to know.

Investing | January 10, 2015

Can You Guess the Most Common Reason People Visit the Doctor?

The most common reason people visit their doctor, according to a study from the Mayo Clinic, may surprise you.

Investing | December 24, 2014

This Cancer Drug War Is Just Getting Started

The FDA approves Bristol-Myers Squibb's Opdivo, pitting it against Merck's Keytruda that was approved earlier this year.

Results 11 - 20 of 766 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY


Advertisement